October 2-4, 2022 | Zurich, Switzerland
There are nearly 100 senior executives registered for our first-ever European conference. The meeting will provide unique opportunities to connect and collaborate with industry leaders while delivering premier content that will benefit your entire team.
The conference topical content, focusing on Trends in Pharma: The Latest Developments in Drug Discovery & Manufacturing, will take place on October 3. A few sessions that day include:
- The Accelerated Evolution and Scaling of mRNA Vaccines from COVID-19 to the Future
Presented by: Dr. Holger Kissel, Vice President Business Alliances, BioNTech
- Financial Overview: The Impact of Developments in Pharma
Presented by: John Pissanos, Managing Director, and Kyle Finegan, Executive Director, of J.P. Morgan Healthcare Investment Banking
|
|
|
With questions, please contact Carol Starke, Meetings & Administration Manager. We look forward to seeing you in Zurich for an only-at-ALDA conference experience! »Register now
|
|
|
October 2-4, 2022
2022 Fall Senior Executive Conference
Zurich, Switzerland
»Register Now
|
|
|
November 2, 2022 (TENTATIVE)
Executive Breakfast at AMP 2022
Phoenix, AZ, US
|
|
|
November 29, 2022
Annual Senior Executive Dinner
Boston, MA, US
|
|
|
February 27, 2023 (TENTATIVE)
Executive Breakfast at SLAS 2023
San Diego, CA, US
|
|
|
April 30-May 2, 2023
ALDA Spring Senior Executive Conference
Boston, MA, US
|
|
|
July 24, 2023 (TENTATIVE)
Executive Breakfast at AACC 2023
Anaheim, CA, US
|
|
|
Tuesday, November 29, 2022
6-9 p.m.
Location: Mistral
Speaker: Nikolai Slavov, Associate Professor, Bioengineering, Northeastern University
Mark your calendars for ALDA's Annual Boston Senior Executive Dinner. Connect with other top regional executives and introduce members of your executive team to the ALDA network.
|
|
Professor Slavov will discuss the latest in single cell proteomics and how this exciting science will impact ALDA member companies and our industry.
Registration opens soon. Please contact Carol Starke with questions.
|
|
|
|
Esco Lifesciences is a life science company with a diverse range of business units, manufacturing laboratory and biopharma equipment, and IVF medical devices.
Official representative: XQ Lin, Chairman & CEO
Alternate representative: Keng Hsu, Group CFO
Headquarters: Horsham, Pennsylvania, US
|
|
|
Gate Scientific provides next generation platforms for life sciences, diagnostic, and analytical applications.
Official representative: Kris Scaboo, President
Alternate representative: Morten Jensen, CEO
Headquarters: Milpitas, California, US
|
|
|
Key Tech is an end-to-end product development firm specializing in the design of complex electro-mechanical devices and systems for medical applications.
Official representative: Alex Flamm, CEO
Alternate representative: Andy Rogers, VP of Business Development
Headquarters: Baltimore, Maryland, US
|
|
|
Lino Bio produces reagent-free biosensors to measure different biological targets directly in crude bioprocess reactor solutions.
Official representative: Mirko Stange, CEO
Headquarters: Zurich, Switzerland
|
|
|
Beckman Coulter Life Sciences appoints Suzanne Foster as President
Foster joins Beckman Coulter Life Sciences from Cardinal Health and brings more than 25 years of experience in the healthcare industry.
»Find out more
|
|
|
Agilent's Certified Pre-Owned Instruments Program Receives Environmental Award
The company's program received a Top Project award for achieving outstanding results in reducing waste.
»Read more
|
|
|
Ginkgo Bioworks Publishes Inaugural Sustainability Report
The report, "Caring at Ginkgo," outlines the company's approach to sustainability, internal governance structures, and more.
»More details on the report
|
|
|
ALDA Member Azenta Acquires B Medical Systems
B Medical is a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe.
»Learn more
|
|
|
ALDA Member SomaLogic Acquires Palamedrix
Palamedrix's technology uses DNA-based biosensors that capture small molecules present in biological samples to pinpoint the presence of any analyte with single-molecule accuracy.
»Acquisition details
|
|
|
ALDA Member Ginkgo Bioworks to Acquire Zymergen
Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
»Read more
|
|
|
|
Share your company news with us! Submit your short news item to us via email. Product/service promotions are prohibited. Questions? Email Andrea Castilow, Marketing & Communications Manager.
|
|
|
ALDA has compiled a variety of ESG-related resources to provide insight and support as your company navigates this landscape. »View the resource page
A few highlights include:
- Seeding Labs - makes affordable, high-quality laboratory equipment available to universities and research institutes in developing countries.
- Springboard - network of influencers, investors, and innovators dedicated to building high-growth companies led by women who are transforming industries.
Please contact us with questions, feedback, or to share an ESG-related resource with the ALDA community.
|
|
SAVE THE DATE: Wednesday, November 2
Is your company attending the AMP (Association for Molecular Pathology) 2022 Annual Meeting in Phoenix, AZ? If so, plan to attend our ALDA breakfast for senior executives on Wednesday morning, November 2.
|
|
|
Our guest speaker will be Dr. Ravindra Kolhe, M.D. Ph.D. FCAP Vice-Chairman, Pathology and Chief, Section of Molecular and Genetic Pathology at the Medical College of Georgia, Augusta University. Dr. Kolhe will discuss lab developed tests, liquid biopsies, and innovative approaches to COVID testing.
Stay tuned for more event details to come. We look forward to seeing you there!
|
|
|
|
